Pulsesight

Developer of non-viral minimally invasive gene therapies for retinal diseases

placeParis, Ile De France, France calendar_todayFounded 2008 language pulsesight.com

Social engagement

Social engagement: 984 social following, 9 posts in the last 12 months — top quartile of its industry.

Investor mix

12 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Pureos Bioventures, Korea Investment Holdings, ND Capital; 1 has since exited.

Investor typeCountShare
Venture capital975%
Bank & private debt217%
Other / undisclosed18%

Recent activity

10 Mar 2026
Event
BioEuropeSpring 2026
22 Jan 2026
Milestone
regulatory
25 Nov 2025
Event
Hanson Wade 6th Annual Dry AMD & Geographic Atrophy Therapeutics Summit
Coming soon